Does the media favor RVMD or ELAN?

In the previous week, Revolution Medicines had 14 more articles in the media than Elanco Animal Health. MarketBeat recorded 18 mentions for Revolution Medicines and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Revolution Medicines' score of 0.56 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revolution Medicines 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ELAN or TEVA?

In the previous week, Teva Pharmaceutical Industries had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 14 mentions for Teva Pharmaceutical Industries and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Teva Pharmaceutical Industries' score of 1.02 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teva Pharmaceutical Industries 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ONC or ELAN?

In the previous week, BeOne Medicines had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for BeOne Medicines and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat BeOne Medicines' score of 0.33 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MRNA or ELAN?

In the previous week, Moderna had 24 more articles in the media than Elanco Animal Health. MarketBeat recorded 28 mentions for Moderna and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Moderna's score of 0.74 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moderna 12 Very Positive mention(s) 7 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELAN or ROIV?

In the previous week, Elanco Animal Health and Elanco Animal Health both had 4 articles in the media. Elanco Animal Health's average media sentiment score of 1.16 beat Roivant Sciences' score of 0.13 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Elanco Animal Health (ELAN) Competitors

$24.84 +0.22 (+0.88%)

Closing price 07/10/2026 03:59 PM Eastern

Extended Trading

$24.82 -0.02 (-0.06%)

As of 07/10/2026 05:41 PM Eastern

Compare

ELAN vs. RVMD, TEVA, ONC, MRNA, and ROIV

Should you buy Elanco Animal Health stock or one of its competitors? MarketBeat compares Elanco Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elanco Animal Health include Revolution Medicines (RVMD), Teva Pharmaceutical Industries (TEVA), BeOne Medicines (ONC), Moderna (MRNA), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.

How does Elanco Animal Health compare to Revolution Medicines?

Revolution Medicines (NASDAQ:RVMD) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Elanco Animal Health has higher revenue and earnings than Revolution Medicines. Elanco Animal Health is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revolution Medicines	$11.58M	3,430.97	-$1.13B	-$7.07	N/A
Elanco Animal Health	$4.72B	2.63	-$232M	-$0.50	N/A

Revolution Medicines has a net margin of 0.00% compared to Elanco Animal Health's net margin of -4.95%. Elanco Animal Health's return on equity of 7.42% beat Revolution Medicines' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revolution Medicines	N/A	-83.22%	-59.06%
Elanco Animal Health	-4.95%	7.42%	3.66%

Revolution Medicines has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market.

94.3% of Revolution Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 7.6% of Revolution Medicines shares are owned by insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Revolution Medicines currently has a consensus price target of $144.00, suggesting a potential downside of 22.95%. Elanco Animal Health has a consensus price target of $28.55, suggesting a potential upside of 14.94%. Given Elanco Animal Health's higher possible upside, analysts clearly believe Elanco Animal Health is more favorable than Revolution Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revolution Medicines	1 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.95
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

In the previous week, Revolution Medicines had 14 more articles in the media than Elanco Animal Health. MarketBeat recorded 18 mentions for Revolution Medicines and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Revolution Medicines' score of 0.56 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revolution Medicines	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elanco Animal Health beats Revolution Medicines on 9 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Elanco Animal Health (NYSE:ELAN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

In the previous week, Teva Pharmaceutical Industries had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 14 mentions for Teva Pharmaceutical Industries and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Teva Pharmaceutical Industries' score of 1.02 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teva Pharmaceutical Industries	10 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.63	-$232M	-$0.50	N/A
Teva Pharmaceutical Industries	$17.26B	2.19	$1.41B	$1.33	24.68

Elanco Animal Health presently has a consensus target price of $28.55, suggesting a potential upside of 14.94%. Teva Pharmaceutical Industries has a consensus target price of $41.78, suggesting a potential upside of 27.29%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, analysts clearly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Teva Pharmaceutical Industries	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by insiders. Comparatively, 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Teva Pharmaceutical Industries has a net margin of 9.01% compared to Elanco Animal Health's net margin of -4.95%. Teva Pharmaceutical Industries' return on equity of 43.53% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
Teva Pharmaceutical Industries	9.01%	43.53%	8.19%

Elanco Animal Health has a beta of 1.68, suggesting that its share price is 68% more volatile than the broader market. Comparatively, Teva Pharmaceutical Industries has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Summary

Teva Pharmaceutical Industries beats Elanco Animal Health on 10 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to BeOne Medicines?

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

BeOne Medicines has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than BeOne Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$5.34B	6.13	$286.93M	$4.47	66.82
Elanco Animal Health	$4.72B	2.63	-$232M	-$0.50	N/A

BeOne Medicines has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market.

BeOne Medicines has a net margin of 8.94% compared to Elanco Animal Health's net margin of -4.95%. BeOne Medicines' return on equity of 12.06% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	8.94%	12.06%	6.69%
Elanco Animal Health	-4.95%	7.42%	3.66%

BeOne Medicines presently has a consensus price target of $391.38, indicating a potential upside of 31.03%. Elanco Animal Health has a consensus price target of $28.55, indicating a potential upside of 14.94%. Given BeOne Medicines' stronger consensus rating and higher possible upside, analysts clearly believe BeOne Medicines is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

In the previous week, BeOne Medicines had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for BeOne Medicines and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat BeOne Medicines' score of 0.33 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

48.6% of BeOne Medicines shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 6.2% of BeOne Medicines shares are held by insiders. Comparatively, 1.1% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

BeOne Medicines beats Elanco Animal Health on 13 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Moderna?

Moderna (NASDAQ:MRNA) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

75.3% of Moderna shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 10.8% of Moderna shares are held by insiders. Comparatively, 1.1% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Elanco Animal Health has higher revenue and earnings than Moderna. Elanco Animal Health is trading at a lower price-to-earnings ratio than Moderna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moderna	$1.94B	13.93	-$2.82B	-$8.15	N/A
Elanco Animal Health	$4.72B	2.63	-$232M	-$0.50	N/A

Moderna has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market.

Elanco Animal Health has a net margin of -4.95% compared to Moderna's net margin of -143.55%. Elanco Animal Health's return on equity of 7.42% beat Moderna's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Moderna	-143.55%	-26.64%	-19.32%
Elanco Animal Health	-4.95%	7.42%	3.66%

In the previous week, Moderna had 24 more articles in the media than Elanco Animal Health. MarketBeat recorded 28 mentions for Moderna and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.16 beat Moderna's score of 0.74 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Moderna	12 Very Positive mention(s)	7 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Moderna presently has a consensus target price of $38.27, indicating a potential downside of 43.95%. Elanco Animal Health has a consensus target price of $28.55, indicating a potential upside of 14.94%. Given Elanco Animal Health's stronger consensus rating and higher probable upside, analysts clearly believe Elanco Animal Health is more favorable than Moderna.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moderna	5 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.83
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

Summary

Elanco Animal Health beats Moderna on 13 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Roivant Sciences?

Elanco Animal Health (NYSE:ELAN) and Roivant Sciences (NASDAQ:ROIV) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

In the previous week, Elanco Animal Health and Elanco Animal Health both had 4 articles in the media. Elanco Animal Health's average media sentiment score of 1.16 beat Roivant Sciences' score of 0.13 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Roivant Sciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Elanco Animal Health has a net margin of -4.95% compared to Roivant Sciences' net margin of -3,629.19%. Elanco Animal Health's return on equity of 7.42% beat Roivant Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
Roivant Sciences	-3,629.19%	-20.54%	-19.43%

Elanco Animal Health has higher revenue and earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.63	-$232M	-$0.50	N/A
Roivant Sciences	$8.26M	3,132.22	-$299.77M	-$0.60	N/A

Elanco Animal Health presently has a consensus target price of $28.55, indicating a potential upside of 14.94%. Roivant Sciences has a consensus target price of $33.59, indicating a potential downside of 6.61%. Given Elanco Animal Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Elanco Animal Health is more favorable than Roivant Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Roivant Sciences	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by insiders. Comparatively, 10.8% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market. Comparatively, Roivant Sciences has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market.

Summary

Elanco Animal Health beats Roivant Sciences on 13 of the 16 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELAN vs. The Competition

Export

Metric	Elanco Animal Health	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$12.30B	$6.27B	$7.12B	$23.43B
Dividend Yield	N/A	1.40%	2.68%	4.04%
P/E Ratio	-49.67	40.95	27.22	31.27
Price / Sales	2.63	28.95	590.16	20.39
Price / Cash	10.61	19.29	49.34	25.05
Price / Book	1.88	3.72	10.90	4.77
Net Income	-$232M	$218.81M	$3.57B	$1.07B
7 Day Performance	-0.42%	-0.27%	-0.25%	-0.50%
1 Month Performance	3.06%	14.79%	5.77%	2.09%
1 Year Performance	66.73%	32.51%	28.14%	16.03%

Elanco Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELAN Elanco Animal Health	3.9229 of 5 stars	$24.84 +0.9%	$28.55 +14.9%	+64.9%	$12.30B	$4.72B	N/A	9,400	Positive News
RVMD Revolution Medicines	1.9884 of 5 stars	$192.62 +5.8%	$132.78 -31.1%	+385.4%	$38.71B	$11.58M	N/A	250	Analyst Forecast
TEVA Teva Pharmaceutical Industries	4.8159 of 5 stars	$33.20 0.0%	$41.78 +25.8%	+98.9%	$38.19B	$17.26B	24.96	33,950	Positive News
ONC BeOne Medicines	4.6719 of 5 stars	$289.99 +3.6%	$390.00 +34.5%	+17.9%	$30.71B	$5.74B	64.87	12,000	Analyst Forecast Insider Trade Gap Up
MRNA Moderna	2.1873 of 5 stars	$69.70 +3.6%	$37.13 -46.7%	+99.2%	$26.69B	$1.94B	N/A	4,700	Trending News Analyst Forecast Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELAN) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elanco Animal Health (ELAN) Competitors

ELAN vs. RVMD, TEVA, ONC, MRNA, and ROIV

How does Elanco Animal Health compare to Revolution Medicines?

Summary

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Summary

How does Elanco Animal Health compare to Moderna?

Summary

How does Elanco Animal Health compare to Roivant Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elanco Animal Health (ELAN) Competitors

ELAN vs. RVMD, TEVA, ONC, MRNA, and ROIV

How does Elanco Animal Health compare to Revolution Medicines?

Which has preferable valuation and earnings, RVMD or ELAN?

Is RVMD or ELAN more profitable?

Which has more risk and volatility, RVMD or ELAN?

Do institutionals & insiders hold more shares of RVMD or ELAN?

Do analysts recommend RVMD or ELAN?

Does the media favor RVMD or ELAN?

Summary

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Does the media prefer ELAN or TEVA?

Which has stronger earnings & valuation, ELAN or TEVA?

Do analysts prefer ELAN or TEVA?

Do insiders and institutionals have more ownership in ELAN or TEVA?

Is ELAN or TEVA more profitable?

Which has more volatility & risk, ELAN or TEVA?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Which has preferable earnings and valuation, ONC or ELAN?

Which has more risk and volatility, ONC or ELAN?

Is ONC or ELAN more profitable?

Do analysts rate ONC or ELAN?

Does the media favor ONC or ELAN?

Do insiders & institutionals believe in ONC or ELAN?

Summary

How does Elanco Animal Health compare to Moderna?

Do institutionals & insiders believe in MRNA or ELAN?

Which has preferable earnings and valuation, MRNA or ELAN?

Which has more volatility and risk, MRNA or ELAN?

Is MRNA or ELAN more profitable?

Does the media prefer MRNA or ELAN?

Do analysts recommend MRNA or ELAN?

Summary

How does Elanco Animal Health compare to Roivant Sciences?

Does the media favor ELAN or ROIV?

Is ELAN or ROIV more profitable?

Which has preferable valuation & earnings, ELAN or ROIV?

Do analysts rate ELAN or ROIV?

Do institutionals & insiders hold more shares of ELAN or ROIV?

Which has more volatility & risk, ELAN or ROIV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools